JP2025041678A5 - - Google Patents

Info

Publication number
JP2025041678A5
JP2025041678A5 JP2024212437A JP2024212437A JP2025041678A5 JP 2025041678 A5 JP2025041678 A5 JP 2025041678A5 JP 2024212437 A JP2024212437 A JP 2024212437A JP 2024212437 A JP2024212437 A JP 2024212437A JP 2025041678 A5 JP2025041678 A5 JP 2025041678A5
Authority
JP
Japan
Prior art keywords
methods
new products
manufacturing methods
manufacturing
methods substantially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024212437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025041678A (ja
Filing date
Publication date
Priority claimed from PCT/GB2019/052980 external-priority patent/WO2020079448A1/en
Application filed filed Critical
Publication of JP2025041678A publication Critical patent/JP2025041678A/ja
Publication of JP2025041678A5 publication Critical patent/JP2025041678A5/ja
Pending legal-status Critical Current

Links

JP2024212437A 2018-10-19 2024-12-05 新規な癌抗原及び方法 Pending JP2025041678A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18201634.5 2018-10-19
EP18201634 2018-10-19
PCT/GB2019/052980 WO2020079448A1 (en) 2018-10-19 2019-10-18 Novel cancer antigens and methods
JP2021546487A JP7712207B2 (ja) 2018-10-19 2019-10-18 新規な癌抗原及び方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021546487A Division JP7712207B2 (ja) 2018-10-19 2019-10-18 新規な癌抗原及び方法

Publications (2)

Publication Number Publication Date
JP2025041678A JP2025041678A (ja) 2025-03-26
JP2025041678A5 true JP2025041678A5 (https=) 2025-07-17

Family

ID=64183836

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021546487A Active JP7712207B2 (ja) 2018-10-19 2019-10-18 新規な癌抗原及び方法
JP2022173369A Active JP7762132B2 (ja) 2018-10-19 2022-10-28 新規な癌抗原及び方法
JP2024212437A Pending JP2025041678A (ja) 2018-10-19 2024-12-05 新規な癌抗原及び方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2021546487A Active JP7712207B2 (ja) 2018-10-19 2019-10-18 新規な癌抗原及び方法
JP2022173369A Active JP7762132B2 (ja) 2018-10-19 2022-10-28 新規な癌抗原及び方法

Country Status (12)

Country Link
US (2) US12263216B2 (https=)
EP (1) EP3866827A1 (https=)
JP (3) JP7712207B2 (https=)
KR (1) KR20210080372A (https=)
CN (2) CN119978090A (https=)
AU (1) AU2019360427A1 (https=)
BR (1) BR112021006941A2 (https=)
CA (1) CA3112427A1 (https=)
EA (1) EA202191081A1 (https=)
IL (1) IL282308A (https=)
MX (1) MX2021004453A (https=)
WO (1) WO2020079448A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021006941A2 (pt) 2018-10-19 2021-08-31 The Francis Crick Institute Limited Antígenos de câncer inovadores e métodos
AU2020302285A1 (en) * 2019-06-28 2021-12-02 Enara Bio Limited Novel cancer antigens and methods
CN116057067A (zh) * 2020-04-17 2023-05-02 弗朗西斯·克里克研究所有限公司 用于治疗黑素瘤的ctl抗原的融合蛋白
JP2023522193A (ja) * 2020-04-17 2023-05-29 ザ フランシス クリック インスティチュート リミティッド 抗原プール

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515734A (ja) 1996-01-02 2002-05-28 カイロン コーポレイション 遺伝子改変された樹状細胞により媒介される免疫刺激
US6770456B1 (en) 1998-07-29 2004-08-03 Ludwig Institute For Cancer Research Endogenous retrovirus tumor associated nucleic acids and antigens
US7504490B1 (en) 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
AU2001238347A1 (en) 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US20020015998A1 (en) 2000-04-06 2002-02-07 Gabriel Vogeli Novel G protein-coupled receptors
US20020082206A1 (en) 2000-05-30 2002-06-27 Leach Martin D. Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
JP2003304877A (ja) 2002-04-15 2003-10-28 Keio Gijuku ヒト色素細胞特異分子
WO2004038003A2 (en) 2002-10-25 2004-05-06 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
EP1586330A1 (en) 2004-04-16 2005-10-19 Georg-August-Universität Göttingen Vaccination against malignant melanoma
DK1871391T3 (da) 2005-03-30 2012-04-16 Viroxis Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
US20070072175A1 (en) 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
EP1963534A2 (en) 2005-12-19 2008-09-03 Genizon Biosciences Inc. Genemap of the human gene associated with crohn's disease
US8921050B2 (en) 2006-03-17 2014-12-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of diagnosing renal cell carcinoma
US20090297530A1 (en) 2006-05-22 2009-12-03 Feng Wang-Johanning Herv-k antigens, antibodies, and methods
US20080019979A1 (en) 2006-05-22 2008-01-24 Feng Wang-Johanning HERV-K Antigens, Antibodies, and Methods
US20100120627A1 (en) 2006-08-02 2010-05-13 Abdelmajid Belouchi Genemap of the human genes associated with psoriasis
EP2118320A4 (en) 2007-02-06 2010-05-19 Genizon Biosciences Inc GENE CARD OF HUMAN GENES ASSOCIATED WITH HYPERACTIVITY ATTENTION DEFICIT DISORDER (ADHD)
US8541553B2 (en) 2007-05-24 2013-09-24 Baxter Healthcare Sa Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein
WO2009026116A2 (en) 2007-08-16 2009-02-26 Genizon Biosciences, Inc. Genemap of the human genes associated with longevity
WO2009039244A2 (en) 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
EP2340851A4 (en) 2008-09-18 2012-09-26 Univ Keio DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
WO2013040142A2 (en) 2011-09-16 2013-03-21 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
TW201326481A (zh) 2011-08-30 2013-07-01 Nat Defense Medical Ct 預測易罹患卵巢贅瘤或卵巢癌預後之生物標記
FR2984362B1 (fr) 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du poumon
WO2014004385A2 (en) 2012-06-25 2014-01-03 Board Of Regents, The University Of Texas System Anti-cancer vaccines
ES2807791T3 (es) 2014-12-08 2021-02-24 Univ Michigan Regents ARN no codificantes y usos de los mismos
GB201521894D0 (en) 2015-12-11 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers
CR20180551A (es) 2016-04-21 2019-02-12 Immatics Biotechnologies Gmbh Inmunoterapia contra el melanoma y otros tipos de cáncer
EP3576751A4 (en) 2017-02-01 2021-08-04 ModernaTX, Inc. RNA ANTI-CANCER VACCINES
BR112021006941A2 (pt) 2018-10-19 2021-08-31 The Francis Crick Institute Limited Antígenos de câncer inovadores e métodos
AU2020302285A1 (en) 2019-06-28 2021-12-02 Enara Bio Limited Novel cancer antigens and methods
MX2021015766A (es) 2019-06-28 2022-01-27 The Francis Crick Institute Ltd Nuevos antigenos y metodos contra el cancer.
WO2021005338A2 (en) 2019-07-05 2021-01-14 The Francis Crick Institute Limited Novel cancer antigens and methods
JP7834016B2 (ja) 2019-07-05 2026-03-23 ザ フランシス クリック インスティチュート リミティッド 新規な癌抗原及び方法

Similar Documents

Publication Publication Date Title
JP2024156852A5 (https=)
JP2024133471A5 (https=)
JP2026012786A5 (https=)
JP2023113641A5 (https=)
JP2025023938A5 (https=)
JP2024037765A5 (https=)
JP2023113681A5 (https=)
JP2026048925A5 (https=)
JP2025106258A5 (https=)
JP2023153863A5 (https=)
JP2023164986A5 (https=)
JP2025118771A5 (https=)
JP2024156705A5 (https=)
JP2023134519A5 (https=)
JP2025038009A5 (https=)
JP2024088648A5 (https=)
JP2023103231A5 (https=)
JP2025143267A5 (https=)
JP2024160274A5 (https=)
JP2023139025A5 (https=)
JP2025124655A5 (https=)
JP2025041678A5 (https=)
JP2023154065A5 (https=)
JP2024038101A5 (https=)
JP2023100679A5 (https=)